Showing 1 - 6 results of 6 for search 'Gideon Shallangwa', query time: 0.02s Refine Results
  1. 1
    Theoretical Investigation and Design of Novel Cephalosporin Based Inhibitors of a DD-carboxypeptidase Enzyme of Salmonella typhimurium

    Theoretical Investigation and Design of Novel Cephalosporin Based Inhibitors of a DD-carboxypeptidase Enzyme of Salmonella typhimurium by Ameji John, Adamu Uzairu, Gideon Shallangwa, Sani UBA

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    In-silico modeling of inhibitory activity and toxicity of some indole derivatives towards designing highly potent dengue virus serotype 2 NS4B inhibitors.

    In-silico modeling of inhibitory activity and toxicity of some indole derivatives towards designing highly potent dengue virus serotype 2 NS4B inhibitors. by Samuel Adawara, Gideon Shallangwa, Paul Mamza, Ibrahim Abdulkadir

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Computational Modeling and Molecular dynamics Simulations of Thiazolino 2-pyridone amide analog compounds as Chlamydia trachomatis inhibitor

    Computational Modeling and Molecular dynamics Simulations of Thiazolino 2-pyridone amide analog compounds as Chlamydia trachomatis inhibitor by Emmanuel Edache, Adamu Uzairu, Paul Mamza, Gideon Shallangwa

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    QSAR Model for Prediction of some Non-Nucleoside Inhibitors of Dengue Virus Serotype 4 NS5 using GFA-MLR Approach

    QSAR Model for Prediction of some Non-Nucleoside Inhibitors of Dengue Virus Serotype 4 NS5 using GFA-MLR Approach by Samuel Adawara, Gideon Shallangwa, Paul Mamza, Abdulkadir Ibrahim

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    In-silico screening, molecular docking, pharmacokinetics studies and design of histone deacetylase inhibitors as anti-Alzheimer agents

    In-silico screening, molecular docking, pharmacokinetics studies and design of histone deacetylase inhibitors as anti-Alzheimer agents by ABDULJELIL Ajala, Adamu Uzairu, Gideon Shallangwa, Stephen Abechi

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Exploring in silico drug design and pharmacokinetics study for identification of potent antidepressant agents

    Exploring in silico drug design and pharmacokinetics study for identification of potent antidepressant agents by Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Shallangwa, Sani Uba

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: